APA (7th ed.) Citation

TH, C., MT, W., JB, W., L, J., B, Y., A, E., & R, D. (2022). MDMA-assisted therapy for posttraumatic stress disorder: A pooled analysis of ethnoracial differences in efficacy and safety from two Phase 2 open-label lead-in trials and a Phase 3 randomized, blinded placebo-controlled trial. Journal of psychopharmacology (Oxford, England), 36(8), 974. https://doi.org/10.1177/02698811221104052

Chicago Style (17th ed.) Citation

TH, Ching, Williams MT, Wang JB, Jerome L, Yazar-Klosinski B, Emerson A, and Doblin R. "MDMA-assisted Therapy for Posttraumatic Stress Disorder: A Pooled Analysis of Ethnoracial Differences in Efficacy and Safety from Two Phase 2 Open-label Lead-in Trials and a Phase 3 Randomized, Blinded Placebo-controlled Trial." Journal of Psychopharmacology (Oxford, England) 36, no. 8 (2022): 974. https://doi.org/10.1177/02698811221104052.

MLA (9th ed.) Citation

TH, Ching, et al. "MDMA-assisted Therapy for Posttraumatic Stress Disorder: A Pooled Analysis of Ethnoracial Differences in Efficacy and Safety from Two Phase 2 Open-label Lead-in Trials and a Phase 3 Randomized, Blinded Placebo-controlled Trial." Journal of Psychopharmacology (Oxford, England), vol. 36, no. 8, 2022, p. 974, https://doi.org/10.1177/02698811221104052.